title: The Saudi Project for Assessment of Coronary Events (SPACE) registry: design and results of a phase I pilot study.
abstract: OBJECTIVE
  The delay between the availability of clinical evidence and its application to the care of patients with acute coronary syndrome (ACS) in the Kingdom of Saudi Arabia remains undefined. The Saudi Project for Assessment of Coronary Events (SPACE) registry provides a comprehensive view of the current diagnostic and treatment strategies for patients with ACS; thus, the registry may be used to identify opportunities to improve the care of these patients.
  
  
  METHODS
  Eight hospitals in different regions of Saudi Arabia were involved in the pilot phase of the registry, from December 2005 to July 2006. The study patients included individuals with ST segment elevation myocardial infarction (STEMI), non-STEMI and unstable angina.
  
  
  RESULTS
  A total of 435 patients (77% men and 80% Saudis) with a mean age of 57.1 years were enrolled. Medical history included previously diagnosed ischemic heart disease (32%), percutaneous coronary intervention (12%), diabetes mellitus (53%), hypertension (48%), current smoking (39%), hyperlipidemia (31%) and family history of premature coronary artery disease (11%). The median door-to-needle time for fibrinolytic therapy received by patients with STEMIs was 90 min. Inhospital medications included acetylsalicylic acid (98%), clopidogrel (73%), angiotensin- converting enzyme inhibitors (74%), beta-blockers (73%), statins (88%), unfractionated heparin (80%), low-molecular weight heparin (22%) and glycoprotein IIb/IIIa inhibitors (9%). The inhospital mortality rate was 5%.
  
  
  CONCLUSIONS
  The first nationwide registry of patients with ACS in the Kingdom of Saudi Arabia is presented. In contrast to registries from developed countries, our cohort is characterized by a younger age at presentation and a much higher prevalence of diabetes mellitus. Most patients with STEMIs did not receive fibrinolytic therapy within the time recommended in the American College of Cardiology/American Heart Association guidelines. The results of the present pilot study show potential targets for improvement in care.
authors: King Fahad Cardiac Centre, College of Medicine, King Saud University, Riyadh 11472, Saudi Arabia. khalidalhabib13@hotmail.com
authors: Khalid F
authors: KF
authors: AlHabib
authors: Ahmad
authors: A
authors: Hersi
authors: Hussam
authors: H
authors: AlFaleh
authors: Mohammad
authors: M
authors: Kurdi
authors: Mohammad
authors: M
authors: Arafah
authors: Mostafa
authors: M
authors: Youssef
authors: Khalid
authors: K
authors: AlNemer
authors: Anas
authors: A
authors: Bakheet
authors: Ayed
authors: A
authors: AlQarni
authors: Tariq
authors: T
authors: Soomro
authors: Amir
authors: A
authors: Taraben
authors: Asif
authors: A
authors: Malik
authors: Waqar Habib
authors: WH
authors: Ahmed
mesh_terms: D054058:Acute Coronary Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D019983:Guideline Adherence; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D017410:Practice Guidelines as Topic; D012042:Registries; D012529:Saudi Arabia / Q000453:epidemiology; D013997:Time Factors
chemical_list: D005343:Fibrinolytic Agents